Scott Williams f361c7df98 Incremental update		2025-03-17 02:05:34 +00:00
..
fragilex.molgen.TA	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.molgen.TB	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.T.disorders_to_consider_in_the	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.T.fmr1_primary_ovarian_insuffic	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.T.fragile_x_syndrome_recommende	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.T.fragile_xassociated_tremorata	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.T.molecular_genetic_testing_use	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.T.odds_ratios_for_fxpoi_by_prem	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.T.recommended_surveillance_for	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.T.recommended_surveillance_for_1	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.T.recommended_surveillance_for_2	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.T.risk_for_an_fmr1_disorder_in	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.T.risk_for_fxtas_by_age_in_male	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.T.treatment_of_manifestations_i	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.T.treatment_of_manifestations_i_1	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.T.types_of_fmr1_repeat_expansio	Incremental update	2025-03-17 02:05:34 +00:00
fragilex.Tc	Incremental update	2025-03-17 02:05:34 +00:00